Related Experiment Videos
Diphenylmethane diisocyanate hypersensitivity pneumonitis: a serologic evaluation
C L Walker1, L C Grammer, M A Shaughnessy
1Department of Medicine, Northwestern University Medical School, Chicago, IL 60611.
Summary
A steel plant worker developed hypersensitivity pneumonitis from diphenylmethane diisocyanate (DMI). Standard tests missed DMI antibodies, highlighting the need for advanced immunoassays to identify reactive chemical causes of lung disease.
Area of Science:
- Occupational Medicine
- Immunology
- Pulmonary Medicine
Background:
- Hypersensitivity pneumonitis (HP) can be challenging to diagnose, especially when the causative antigen is not readily apparent.
- Reactive chemical inhalants, such as diphenylmethane diisocyanate (DMI), pose a risk in industrial settings.
- Traditional diagnostic methods for HP may not detect all causative agents.
Observation:
- A steel plant maintenance supervisor presented with symptoms consistent with HP.
- Despite initial investigations, the specific antigen was not immediately identified.
- A detailed occupational history and industrial hygiene review pointed to DMI as the likely culprit.
Findings:
- Standard serological tests for precipitating antibodies to DMI were negative.
- Advanced immunoassays detected significant IgG antibody levels specific for diphenylmethane diisocyanate-human serum albumin conjugate.
- This suggests that DMI exposure was the cause of HP in this patient.
Implications:
- The case underscores the critical role of comprehensive occupational history and advanced immunologic testing in diagnosing HP.
- It highlights that HP from reactive chemicals like DMI can occur even without detectable precipitating antibodies.
- This emphasizes the need for tailored diagnostic approaches for chemically induced lung diseases.